Drug Shortage Report for ULTRAVATE
| Report ID | 137589 |
| Drug Identification Number | 01962701 |
| Brand name | ULTRAVATE |
| Common or Proper name | ULTRAVATE |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | HALOBETASOL PROPIONATE |
| Strength(s) | 0.05% |
| Dosage form(s) | CREAM |
| Route of administration | TOPICAL TOPICAL |
| Packaging size | 50g |
| ATC code | D07AC |
| ATC description | CORTICOSTEROIDS, PLAIN |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2021-04-13 |
| Estimated end date | |
| Actual end date | 2021-05-11 |
| Shortage status | Resolved |
| Updated date | 2021-05-19 |
| Company comments | waiting QA release |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-05-19 | French | Compare |
| v5 | 2021-05-19 | English | Compare |
| v4 | 2021-04-21 | French | Compare |
| v3 | 2021-04-21 | English | Compare |
| v2 | 2021-04-16 | French | Compare |
| v1 | 2021-04-16 | English | Compare |
Showing 1 to 6 of 6